Overview

Phase 3 Study of Deoxycholic Acid Injection (ATX-101) Versus Placebo for the Reduction of Localized Subcutaneous Fat in the Submental Area

Status:
Completed
Trial end date:
2013-08-01
Target enrollment:
Participant gender:
Summary
To evaluate the safety and efficacy of deoxycholic acid injection in the reduction of submental fat (fat below the chin).
Phase:
Phase 3
Details
Lead Sponsor:
Kythera Biopharmaceuticals
Treatments:
Deoxycholic Acid